美中嘉和子公司获质子治疗设备注册证

财中社
09 Dec 2024

  美中嘉和(02453)发布公告,宣布其子公司广州泰和肿瘤医院有限公司已成功获得质子治疗设备医疗器械注册证的批准。该注册证的申请由国家药品监督管理局于2024年12月6日批准,标志着公司在质子治疗领域的重要进展。

  根据公告,公司于2024年4月29日已向国家卫生健康委员会提交了大型医用设备配置许可证的申请,并于2024年9月13日获得批准。目前,质子治疗服务的运营将尽快开始,具体时间将视各项部署情况而定。公司表示将适时提供有关质子治疗服务的最新进展信息。

(文章来源:财中社)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10